Anti-Apoptotic Effects of Carotenoids in Neurodegeneration

Apoptosis, programmed cell death type I, is a critical part of neurodegeneration in cerebral ischemia, Parkinson’s, and Alzheimer’s disease. Apoptosis begins with activation of pro-death proteins Bax and Bak, release of cytochrome c and activation of caspases, loss of membrane integrity of intracell...

Full description

Bibliographic Details
Main Authors: Han-A Park, Mary Margaret Hayden, Sydni Bannerman, Joseph Jansen, Kristi M. Crowe-White
Format: Article
Language:English
Published: MDPI AG 2020-07-01
Series:Molecules
Subjects:
Online Access:https://www.mdpi.com/1420-3049/25/15/3453
_version_ 1797560957474439168
author Han-A Park
Mary Margaret Hayden
Sydni Bannerman
Joseph Jansen
Kristi M. Crowe-White
author_facet Han-A Park
Mary Margaret Hayden
Sydni Bannerman
Joseph Jansen
Kristi M. Crowe-White
author_sort Han-A Park
collection DOAJ
description Apoptosis, programmed cell death type I, is a critical part of neurodegeneration in cerebral ischemia, Parkinson’s, and Alzheimer’s disease. Apoptosis begins with activation of pro-death proteins Bax and Bak, release of cytochrome c and activation of caspases, loss of membrane integrity of intracellular organelles, and ultimately cell death. Approaches that block apoptotic pathways may prevent or delay neurodegenerative processes. Carotenoids are a group of pigments found in fruits, vegetables, and seaweeds that possess antioxidant properties. Over the last several decades, an increasing number of studies have demonstrated a protective role of carotenoids in neurodegenerative disease. In this review, we describe functions of commonly consumed carotenoids including lycopene, β-carotene, lutein, astaxanthin, and fucoxanthin and their roles in neurodegenerative disease models. We also discuss the underlying cellular mechanisms of carotenoid-mediated neuroprotection, including their antioxidant properties, role as signaling molecules, and as gene regulators that alleviate apoptosis-associated brain cell death.
first_indexed 2024-03-10T18:07:41Z
format Article
id doaj.art-f34a57d0e8f943d29786eda68ed8bc20
institution Directory Open Access Journal
issn 1420-3049
language English
last_indexed 2024-03-10T18:07:41Z
publishDate 2020-07-01
publisher MDPI AG
record_format Article
series Molecules
spelling doaj.art-f34a57d0e8f943d29786eda68ed8bc202023-11-20T08:22:32ZengMDPI AGMolecules1420-30492020-07-012515345310.3390/molecules25153453Anti-Apoptotic Effects of Carotenoids in NeurodegenerationHan-A Park0Mary Margaret Hayden1Sydni Bannerman2Joseph Jansen3Kristi M. Crowe-White4Department of Human Nutrition and Hospitality Management, College of Human Environmental Sciences, The University of Alabama, Tuscaloosa, AL 35487, USADepartment of Human Nutrition and Hospitality Management, College of Human Environmental Sciences, The University of Alabama, Tuscaloosa, AL 35487, USADepartment of Human Nutrition and Hospitality Management, College of Human Environmental Sciences, The University of Alabama, Tuscaloosa, AL 35487, USADepartment of Human Nutrition and Hospitality Management, College of Human Environmental Sciences, The University of Alabama, Tuscaloosa, AL 35487, USADepartment of Human Nutrition and Hospitality Management, College of Human Environmental Sciences, The University of Alabama, Tuscaloosa, AL 35487, USAApoptosis, programmed cell death type I, is a critical part of neurodegeneration in cerebral ischemia, Parkinson’s, and Alzheimer’s disease. Apoptosis begins with activation of pro-death proteins Bax and Bak, release of cytochrome c and activation of caspases, loss of membrane integrity of intracellular organelles, and ultimately cell death. Approaches that block apoptotic pathways may prevent or delay neurodegenerative processes. Carotenoids are a group of pigments found in fruits, vegetables, and seaweeds that possess antioxidant properties. Over the last several decades, an increasing number of studies have demonstrated a protective role of carotenoids in neurodegenerative disease. In this review, we describe functions of commonly consumed carotenoids including lycopene, β-carotene, lutein, astaxanthin, and fucoxanthin and their roles in neurodegenerative disease models. We also discuss the underlying cellular mechanisms of carotenoid-mediated neuroprotection, including their antioxidant properties, role as signaling molecules, and as gene regulators that alleviate apoptosis-associated brain cell death.https://www.mdpi.com/1420-3049/25/15/3453apoptosismitochondriacarotenoidneurodegenerationantioxidant
spellingShingle Han-A Park
Mary Margaret Hayden
Sydni Bannerman
Joseph Jansen
Kristi M. Crowe-White
Anti-Apoptotic Effects of Carotenoids in Neurodegeneration
Molecules
apoptosis
mitochondria
carotenoid
neurodegeneration
antioxidant
title Anti-Apoptotic Effects of Carotenoids in Neurodegeneration
title_full Anti-Apoptotic Effects of Carotenoids in Neurodegeneration
title_fullStr Anti-Apoptotic Effects of Carotenoids in Neurodegeneration
title_full_unstemmed Anti-Apoptotic Effects of Carotenoids in Neurodegeneration
title_short Anti-Apoptotic Effects of Carotenoids in Neurodegeneration
title_sort anti apoptotic effects of carotenoids in neurodegeneration
topic apoptosis
mitochondria
carotenoid
neurodegeneration
antioxidant
url https://www.mdpi.com/1420-3049/25/15/3453
work_keys_str_mv AT hanapark antiapoptoticeffectsofcarotenoidsinneurodegeneration
AT marymargarethayden antiapoptoticeffectsofcarotenoidsinneurodegeneration
AT sydnibannerman antiapoptoticeffectsofcarotenoidsinneurodegeneration
AT josephjansen antiapoptoticeffectsofcarotenoidsinneurodegeneration
AT kristimcrowewhite antiapoptoticeffectsofcarotenoidsinneurodegeneration